Reason for request
Renewal of inclusion
-
Clinical Benefit
| Substantial |
The Committee considers that the actual benefit of ALTIM remains substantial in rheumatological diseases : - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren's contracture. |
| Unspecified |
The Committee does not make any comment on the actual benefit of ALTIM in the epidural injection indication : radiculalgia, pending the re-assessment of ALTIM 3.75 mg/1.5 ml suspension for injection an d HYDROCORTANCYL 2.5 % suspension for injection in this single indication. |
